Reviva Pharmaceuticals Holdings Inc.

11/12/2024 | Press release | Distributed by Public on 11/12/2024 07:07

Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia Earnings Release